Research animal retirement and lifetime care, now available through Alpha Genesis. Professionally managed lifetime care for retired research primates, with expert social reintroduction into stable outdoor groups led by veterinary staff deeply experienced in laboratory-animal medicine.
Learn more
Capability
In-life support for AAV and other gene-therapy programs across rodent and NHP models, from early proof-of-concept in disease models through translational biodistribution, immunogenicity, and GLP-aligned safety studies.
What we support
Early proof-of-concept in disease-relevant rodent and NHP models.
Vector biodistribution and tissue-targeting studies.
Vector and transgene immunogenicity assessment.
Safety studies with GLP-aligned documentation for IND-enabling decisions.
IV, intrathecal, intracranial, and other route development.
Serial and terminal collection with cold-chain logistics.
Move from early disease-model work into NHP translational studies with one partner.
NHP cohorts matched by AAV serostatus where the design requires it.
Complex delivery routes performed by experienced technical and veterinary teams.
Records built to support IND-enabling and regulatory review.
Quality & welfare
Exceptional care is the foundation of reliable data.
Yes. NHP cohorts can be matched by AAV status where a program requires it, drawing on our large colony and screening capabilities.